Image may be NSFW.
Clik here to view.
Clik here to view.
Amarantus on road to commercializing AD test
Amarantus Bioscience Holdings’ (OTCQB:AMBS) master services agreement with the lab services arm of ICON (NASDAQ:ICLR) puts Amarantus on the road to commercializing its LymPro diagnostic blood test for...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Amarantus and Anavex in AD biomarker collaboration
Amarantus BioScience Holdings (OTCQB:AMBS) and Anavex Life Sciences (OTCQX:AVXL) have signed a biomarker services agreement in which Amarantus will evaluate the pharmacodynamic effect of ANAVEX 2-73...
View Article
More Pages to Explore .....
